3Luo L, Li DQ, Doshi A, et al. Experimental dry eye stimulates production of inflammatory cytokines and MMP - 9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthahnol Vis Sci, 2004,45(12) :4293 -4301.
4Seo M J, Kim JM, Lee M J, Sohn YS, Kaug KK, Yoo M. The therapeutic effect of DA - 6034 on ocular inflammation via suppression of MMP-9 and inflammatory cytokines and activation of the MAPK signaling pathway in an experimental dry eye model. Curr Eye Res, 2010.35(2):165 - 175.
5Liu Y, Kimura K, Yanai R, et al. Cytokine, chemokine, and adhesion molecule expression mediated by MAPKs in human corneal fibro- blasts exposed to poly (I: C ). Invest Ophthalmol Vis Sci, 2008,49 (8) :3336 - 3344.
6Adhikary G, Sun Y, Pearlman E. C - Jun NH2 terminal kinase (JNK) is an essential mediator of Toll - like receptor 2 - induced cor- neal inflammation. J Leukoc Bio1,2008,83 (4) :991 - 997.
7Kimura K, Teranishi S, Yamauchi J, et al. Role of JNK -dependent serine phosphorylation of paxillin in migration of corneal epithelial cells during wound closure. Invest Ophthalmol Vis Sci,2008,49( 1 ) : 125 - 132.
8Okada Y, Saika S, Shirai K,et al. JNK MAPK signaling contributes in vivo to injury - induced corneal epithelial migration. Ophthalmic Res, 2009,42(4) :185 - 192.
9Li DQ, Chen Z, Song XJ, et al. Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial ce lls. Invest Ophthalmol Vis Sci ,2004,45 (12) :4302 -4311.
10Shivanna M, Rajashekhar G, Srinivas SP. Barrier dysfunction of the corneal endothelium in response to TNF -alpha: role of p38 MAP ki- nase. Invest Ophthalmol Vis Sci,2010,51 ( 3 ) : 1575 - 1582.
二级参考文献30
1Kisseleva T, Bhattacharya S, Braunstein J, et al. Signaling through the JAK/STAT pathway, recent advances and future challenges[J]. Gene, 2002, 285(1): 1 - 24.
2Dent P, Yacoub A, Fisher PB, et al. MAPK pathways in radiation responses [ J ]. Oncogene, 2003, 22 (37): 5885 -5896.
3Arbabi S, Maier RV. Mitogen- activated protein kinases[J].Crit Care Med, 2002, 30(Suppl 1): S74- S79.
4Sanchez MV, Martin RC, Santos AJ, et al. Role of leptin as an immunomodulator of blood mononuclear cells: mechanisms of action[J]. Clin Exp Immunol, 2003, 133(1): 11 - 19.
5Digicaylioglu M, Lipton S. Erythropoietin- mediated neuroprotection involves cross- talk between JAK2 and NF - κB signaling cascades[J]. Nature, 2001, 412(6847): 641-647.
6Dhawan P, Richmond A. A novel NF- kappa B- inducing kinase - MAPK signaling pathway up- regulates NF - kappa B activity in melanoma cells[J]. J Biol Chem, 2002, 277(10):7920 - 7928.
7Craig R, Larkin A, Mingo AM, et al. p38 MAPK and NFkappa B collaborate to induce interleukin- 6 gene expression and release[J]. J Biol Chem, 2000, 275(31): 23814-23824.
8Bradbury CM, Markovina S, Wei SJ, et al. Indomethacininduced radiosensitization and inhibition of ionizing radiationinduced NF - kappa B activation in HeLa cells occur via a mechanism involving p38 MAP kinase[J]. Cancer Res, 2001,61(20): 7689 - 7696.
9Galdiero M, Vitiello M, Sanzari E, et al. Porins from Salmonella enterica serovar typhimurium activate the transcription factors activating protein 1 and NF- kappa B through the Raf- 1 - mitogen- activated protein kinase cascade[J]. Infect Immun, 2002, 70(2): 558- 568.
10Conejo R, de Alvaro C, Benito M, et al. Insulin restores differentiation of Ras- transformed C2C12 myoblasts by inducing NF- kappa B through an AKT/P70S6K/p38 - MAPK pathway [J]. Oncogene, 2002, 21(23): 3739-3753.
1Hardwicke J, Song B, Moseley R, et al. Investigation of the potentialof polymer therapeutics in corneal re - epithelialisation. Br J Ophthalmol2010;94(12) :1566-1570.
2Holland S,Morck D, Schultz C. Treatment of comeal defects withdelayed re - epithelization with a medical device/ drug delivery system forepidermal growth factor. Clin Experiment Ophthalmol 2012;40(7) :662-668.
